GoodRx Holdings, Inc. (GDRX)
NASDAQ: GDRX · Real-Time Price · USD
4.080
-0.110 (-2.63%)
At close: Sep 15, 2025, 4:00 PM EDT
4.090
+0.010 (0.25%)
After-hours: Sep 15, 2025, 4:55 PM EDT
GoodRx Holdings Stock Forecast
Stock Price Forecast
The 8 analysts that cover GoodRx Holdings stock have a consensus rating of "Buy" and an average price target of $5.88, which forecasts a 44.12% increase in the stock price over the next year. The lowest target is $5.00 and the highest is $7.00.
Price Target: $5.88 (+44.12%)
Analyst Consensus: Buy
* Price targets were last updated on May 13, 2025.
Analyst Ratings
The average analyst rating for GoodRx Holdings stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Buy | 6 | 6 | 6 | 6 | 6 | 3 |
| Hold | 3 | 4 | 4 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 12 | 12 | 12 | 12 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Hold Maintains $6 → $5.25 | Hold | Maintains | $6 → $5.25 | +28.68% | May 13, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $6 → $5 | Hold | Maintains | $6 → $5 | +22.55% | May 9, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $8 → $7 | Buy | Maintains | $8 → $7 | +71.57% | Apr 29, 2025 |
| Truist Securities | Truist Securities | Hold Maintains $6.5 → $5.5 | Hold | Maintains | $6.5 → $5.5 | +34.80% | Apr 10, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $9 → $8 | Buy | Maintains | $9 → $8 | +96.08% | Feb 28, 2025 |
Financial Forecast
Revenue This Year
814.69M
from 792.32M
Increased by 2.82%
Revenue Next Year
857.94M
from 814.69M
Increased by 5.31%
EPS This Year
0.38
from 0.04
Increased by 854.87%
EPS Next Year
0.46
from 0.38
Increased by 20.95%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 853.0M | 915.0M | |||
| Avg | 814.7M | 857.9M | |||
| Low | 778.1M | 799.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 7.7% | 12.3% | |||
| Avg | 2.8% | 5.3% | |||
| Low | -1.8% | -1.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 0.42 | 0.54 | |||
| Avg | 0.38 | 0.46 | |||
| Low | 0.33 | 0.38 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 950.0% | 40.2% | |||
| Avg | 854.9% | 21.0% | |||
| Low | 733.0% | 0.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.